147 related articles for article (PubMed ID: 11590384)
1. Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14.
Alexis NE; Peden DB
J Allergy Clin Immunol; 2001 Oct; 108(4):577-80. PubMed ID: 11590384
[TBL] [Abstract][Full Text] [Related]
2. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy.
Alexis N; Eldridge M; Reed W; Bromberg P; Peden DB
J Allergy Clin Immunol; 2001 Jan; 107(1):31-5. PubMed ID: 11149987
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
[TBL] [Abstract][Full Text] [Related]
4. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids.
Kelly MM; Leigh R; Jayaram L; Goldsmith CH; Parameswaran K; Hargreave FE
J Allergy Clin Immunol; 2006 May; 117(5):989-94. PubMed ID: 16675323
[TBL] [Abstract][Full Text] [Related]
6. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
Subbarao P; Dorman SC; Rerecich T; Watson RM; Gauvreau GM; O'Byrne PM
J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
8. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
9. Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy.
Michel O; Dentener M; Corazza F; Buurman W; Rylander R
J Allergy Clin Immunol; 2001 May; 107(5):797-804. PubMed ID: 11344345
[TBL] [Abstract][Full Text] [Related]
10. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
11. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
[TBL] [Abstract][Full Text] [Related]
12. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL
Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383
[TBL] [Abstract][Full Text] [Related]
13. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
[TBL] [Abstract][Full Text] [Related]
14. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma.
Woodruff PG; Khashayar R; Lazarus SC; Janson S; Avila P; Boushey HA; Segal M; Fahy JV
J Allergy Clin Immunol; 2001 Nov; 108(5):753-8. PubMed ID: 11692100
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
16. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
17. Effect of histamine and adenosine 5'-monophosphate provocation on sputum neutrophils and related mediators in atopic patients.
Pohl D; Beier J; Buhl R; Beeh KM
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):197-203. PubMed ID: 16136771
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
19. Sensitive responses of leukocytes to lipopolysaccharide require a protein distinct from CD14 at the cell surface.
Vasselon T; Pironkova R; Detmers PA
J Immunol; 1997 Nov; 159(9):4498-505. PubMed ID: 9379050
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma.
Lensmar C; Katchar K; Eklund A; Grunewald J; Wahlström J
Respir Med; 2006 May; 100(5):918-25. PubMed ID: 16202577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
